About Emzumab 150 Mg Injection
Omalizumab 150 mg Injection is a monoclonal antibody used in the treatment of moderate to severe persistent allergic asthma and chronic spontaneous urticaria (chronic hives) in patients who do not respond adequately to standard therapy. It works by targeting and binding to Immunoglobulin E (IgE), thereby reducing allergic inflammation and improving symptom control. This injection is widely prescribed by specialists and is administered under medical supervision to ensure safety and effectiveness. Key Benefits Effective in controlling severe allergic asthma Reduces frequency of asthma attacks and hospitalizations Helps manage chronic spontaneous urticaria (hives) Improves overall respiratory function and quality of life Long-acting monoclonal antibody therapy Uses Moderate to severe allergic asthma Chronic spontaneous urticaria (CSU) Storage Instructions Store between 2C to 8C Do not freeze Protect from light Safety Information To be administered by a qualified healthcare professional Dosage and frequency as prescribed by the physician Not recommended for self-medication
Key Features of Emzumab 150 Mg InjectionEmzumab 150 Mg Injection utilizes Omalizumab, designed to manage allergic conditions such as chronic idiopathic urticaria and asthma. This innovative product comes as a single-use vial accompanied by a solvent ampoule. It is intended for subcutaneous use only, requiring healthcare professional supervision to ensure patient safety and efficacy.
Precise Dosage and Simple ReconstitutionThe package contains a 150 mg dose of Omalizumab in a lyophilized, white to off-white powder form. It must be reconstituted just before administration using the provided water for injection. Accurate reconstitution and administration are essential for the medication to function effectively and safely.
Safe Storage and HandlingTo maintain its efficacy, Emzumab 150 Mg Injection should be stored at a temperature between 2C and 8C, taking care never to freeze the vial. The product comes in a robust glass container to ensure stability. Use within 24 hours of reconstitution, following all proper handling protocols to avoid contamination or reduced effectiveness.
FAQ's of Emzumab 150 Mg Injection:
Q: How should Emzumab 150 Mg Injection be reconstituted and administered?
A: Emzumab 150 Mg Injection must be reconstituted with the provided water for injection in the solvent ampoule. Dissolve the lyophilized powder completely under sterile conditions, and administer the solution subcutaneously, strictly under medical supervision.
Q: What are the indications for using Emzumab 150 Mg Injection?
A: This medication is used to treat chronic idiopathic urticaria and moderate to severe persistent asthma in patients who require additional therapy for symptom control.
Q: When should Emzumab 150 Mg Injection be used after reconstitution?
A: After mixing with the solvent, Emzumab should be used within 24 hours. Store the reconstituted solution in the refrigerator (2C-8C) if not administered immediately, and never freeze it.
Q: Where should Emzumab 150 Mg Injection be stored before and after reconstitution?
A: Store the unopened vial and solvent ampoule in the refrigerator at 2C-8C. After reconstitution, keep the solution refrigerated and use it within 24 hours. Do not freeze at any time.
Q: What precautions should be taken during Emzumab 150 Mg Injection administration?
A: Administration must occur under the supervision of a healthcare professional. Monitor the patient for possible allergic reactions, especially anaphylaxis, during and after injection.
Q: What makes Emzumab 150 Mg Injection beneficial for patients?
A: Emzumab is a targeted monoclonal antibody therapy that helps control severe allergic conditions unresponsive to standard treatments, improving patients' quality of life.
Q: Can Emzumab 150 Mg Injection be purchased without a prescription?
A: No, Emzumab requires a doctor's prescription and should only be administered by or under the guidance of a qualified healthcare provider.